Name | N-(2-Hydroxyethyl)-4-(6-{[4-(trifluoromethoxy)phenyl]amino}-4-pyrimidinyl)benzamide |
---|---|
Synonyms |
N-(2-Hydroxyethyl)-4-(6-{[4-(trifluoromethoxy)phenyl]amino}-4-pyrimidinyl)benzamide
Benzamide, N-(2-hydroxyethyl)-4-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]- N-(2-hydroxyethyl)-4-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide |
Description | Multi-kinase inhibitor 1 is a potent multi-kinase inhibitor. Multi-kinase inhibitor 1 has the potential for diseases or disorders associated with abnormal or deregulated tyrosine kinase activity, particularly diseases associated with the activity of PDGF-R, c-Kit and Bcr-abl[1]. |
---|---|
Related Catalog | |
Target |
PDGFR Bcr-Abl |
In Vitro | Multi-kinase inhibitor 1 (compound 68) is a potent multi-kinase inhibitor. The protein kinases represent a large family of proteins, which play a central role in the regulation of a wide variety of cellular processes and maintaining control over cellular function. These kinases include receptor tyrosine kinases, such as platelet derived growth factor receptor kinase(PDGF-R), the receptor kinase for stem cell factor, c-Kit, and non-receptor tyrosine kinases, such as the fusion kinase Bcr-abl[1]. |
References |
[1]. Qiang Ding, et al. Novel compounds and compositions as protein kinase inhibitors. WO2004089286A2. |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 615.9±55.0 °C at 760 mmHg |
Molecular Formula | C20H17F3N4O3 |
Molecular Weight | 418.369 |
Flash Point | 326.3±31.5 °C |
Exact Mass | 418.125275 |
LogP | 3.20 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.600 |
Storage condition | -20℃ |